ISRG Stock Analysis: Buy, Sell, or Hold?
ISRG - Intuitive Surgical Inc.
$504.22
-3.33 (-0.66%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Apr 21, 2026
Get Alerted When ISRG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ISRG this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ISRG trading at deep discount. Market pricing in -7.7% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: ISRG trading at deep discount. Market pricing in -7.7% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$439.40
Based on 9.0% avg growth
INTRINSIC VALUE TODAY
$272.83
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ISRG is currently trading at $504.22, which is considered oversold relative to its 30-day fair value range of $526.83 to $581.21. From a valuation perspective, the stock is trading at a discount (Forward PE: 44.4) compared to its historical average (56.5). Remarkably, the market is currently pricing in an annual earnings decline of 7.7% over the next few years. This pessimistic expectation contrasts with the company's recent 17.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ISRG is in a strong downtrend. The price is currently testing key support at $501.38. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $611.82 (+20.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ISRG is in a strong downtrend. The price is currently testing key support at $501.38. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $611.82 (+20.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$526.83 -
$581.21
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.5% below Wall St target ($611.82)
Fair Price Analysis
30-Day Fair Range
$526.83 -
$581.21
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$501.39
Resistance Level
$543.00
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
44.41
Wall Street Target
$611.82
(+20.5%)
Revenue Growth (YoY)
18.8%
Earnings Growth (YoY)
17.1%
Profit Margin
28.4%
Valuation Discount vs History
-7.7% cheaper
PE vs Historical
44.4 vs 56.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.7%
(market-implied from PE analysis)
1-Year Target
$468.47
(-8%)
2-Year Target
$432.40
(-15%)
3-Year Target
$399.10
(-21%)
3-Yr Target (if PE normalizes)
(PE: 44→57)
$507.71
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 44.4, Growth: 14.1%)
$753.87
(+49%)
Base:
(SPY PE: 22.3, Growth: 14.1%)
$378.52
(-25%)
Bear:
(PE: 19.0, Growth: 14.1%)
$321.74
(-37%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (66x PE), but valuation improves significantly next year (44x PE) as earnings recover.
Trailing PE: 66.25 | Current EPS (TTM): $7.88
Bull Case
$832.78
(+65%)
Analyst growth 45.0%, PE expands to 72.9
Base Case
$757.07
(+50%)
Market implied 45.0%, PE stable at 66.3
Bear Case
$354.99
(-30%)
Severe decline -20.0%, PE contracts to 56.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 44.4 to 56.5
Stabilization Target:
$645.67
(+27.2%)
PE Expansion Potential:
+27.2%
Last updated: January 30, 2026 7:45 PM ET
Data refreshes hourly during market hours. Next update: 8:45 PM
Data refreshes hourly during market hours. Next update: 8:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ISRG showing a specific setup today?
Insider Activity (6 Months)
2
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Markwayne Mullin
BUY
2025-09-24
Ro Khanna
BUY
2025-09-05
Amy L Ladd
SELL
335 shares
2025-09-04
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 58 HOLD |
Advanced ISRG Option Strategies
Professional options setups generated by AI based on today's ISRG price and gamma walls.
